» Articles » PMID: 28573610

Production of Filovirus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus for Study of Filovirus Entry Mechanisms

Overview
Specialty Molecular Biology
Date 2017 Jun 3
PMID 28573610
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Members of the family Filoviridae are filamentous, enveloped, and nonsegmented negative-stranded RNA viruses that can cause severe hemorrhagic disease in humans and nonhuman primates with high mortality rates. Current efforts to analyze the structure and biology of these viruses as well as the development of antivirals have been hindered by the necessity of biosafety level 4 containment (BSL4). Here, we outline how to produce and work with Ebola virus glycoprotein bearing vesicular stomatitis virus (VSV) pseudovirions. These pseudovirions can be safely used to evaluate early steps of the filovirus life cycle without need for BSL4 containment. Virus gene expression in the transduced cells is easy to assess since the pseudovirions encode a reporter gene in place of the VSV G glycoprotein gene. Adoption of VSV for use as a pseudovirion system for filovirus GP has significantly expanded access for researchers to study specific aspects of the viral life cycle outside of BSL4 containment and has allowed substantial growth of filovirus research.

Citing Articles

Identification of Filovirus Entry Inhibitors from Marine Fungus-Derived Indole Alkaloids.

Wang L, Seravalli J, Eaton B, Liu Y, Holbrook M, Lan W Mar Drugs. 2025; 23(1).

PMID: 39852525 PMC: 11766795. DOI: 10.3390/md23010023.


Discovery of Thiophene Derivatives as Potent, Orally Bioavailable, and Blood-Brain Barrier-Permeable Ebola Virus Entry Inhibitors.

Morales-Tenorio M, Lasala F, Garcia-Rubia A, Aledavood E, Heung M, Olal C J Med Chem. 2024; 67(18):16381-16402.

PMID: 39248591 PMC: 11440591. DOI: 10.1021/acs.jmedchem.4c01267.


Macaque antibodies targeting Marburg virus glycoprotein induced by multivalent immunization.

Janus B, Wang R, Cleveland 4th T, Metcalf M, Lemmer A, van Dyk N J Virol. 2024; 98(7):e0015524.

PMID: 38832790 PMC: 11329191. DOI: 10.1128/jvi.00155-24.


Modification of N-Linked Glycan Sites in Viral Glycoproteins.

Lennemann N, Corliss L, Maury W Methods Mol Biol. 2024; 2762:27-41.

PMID: 38315358 DOI: 10.1007/978-1-0716-3666-4_3.


Pseudotyped Viruses for Marburgvirus and Ebolavirus.

Zhang L, Liu S, Wang Y Adv Exp Med Biol. 2023; 1407:105-132.

PMID: 36920694 DOI: 10.1007/978-981-99-0113-5_6.


References
1.
Schnell M, Buonocore L, Kretzschmar E, Johnson E, Rose J . Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci U S A. 1996; 93(21):11359-65. PMC: 38062. DOI: 10.1073/pnas.93.21.11359. View

2.
Tani H, Iha K, Shimojima M, Fukushi S, Taniguchi S, Yoshikawa T . Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus. J Virol. 2014; 88(13):7317-30. PMC: 4054455. DOI: 10.1128/JVI.00512-14. View

3.
Ito H, Watanabe S, Sanchez A, Whitt M, Kawaoka Y . Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol. 1999; 73(10):8907-12. PMC: 112919. DOI: 10.1128/JVI.73.10.8907-8912.1999. View

4.
Takada A, Robison C, Goto H, Sanchez A, Murti K, Whitt M . A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A. 1998; 94(26):14764-9. PMC: 25111. DOI: 10.1073/pnas.94.26.14764. View

5.
Ray N, Whidby J, Stewart S, Hooper J, Bertolotti-Ciarlet A . Study of Andes virus entry and neutralization using a pseudovirion system. J Virol Methods. 2009; 163(2):416-23. DOI: 10.1016/j.jviromet.2009.11.004. View